Physician profile
John R Mcintyre
NPI 1588776710
$72,669.06
in general payments reported to CMS, 2019-2025
15 companies · $585 in 2025
The $585 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $17K · 2021: $27K · 2022: $5,741 · 2023: $4,717 · 2024: $1,474 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,582 · Travel and Lodging: $3,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,582.17 |
| Travel and Lodging | $3,194.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $42,702.77 | 2019-2025 | Total30, Precision 1, Precision7 |
| Coopervision INC. | $27,186.42 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $873.08 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $576.84 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $319.73 | 2024-2025 | Infuse |
| Johnson & Johnson Vision Care, INC. | $306.21 | 2019-2025 | Acuvue |
| Glaukos Corporation | $218.06 | 2022-2024 | Kxl System (Not Refurbished), Istent Inject Trabecular Micro-Bypass System, Radius |
| Rxsight INC | $110.86 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $110.60 | 2020 | |
| Biotissue Holdings INC. | $93.26 | 2022 | |
| Abbvie INC. | $61.07 | 2022-2023 | |
| Lkc Technologies, INC. | $44.85 | 2025 | |
| Optos, INC. | $37.57 | 2022 | |
| Sun Pharmaceutical Industries INC. | $14.72 | 2020 | |
| Allergan, INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.